Biotherapeutics discovery programs

Where number of screened cells, assays relevance and readout resolution opens opportunities of discovery unthinkable with other tech, we’re building development collaborations, from target to lead biotherapeutics.

We are happy to explore how we can help you to overcome your current technological limitations to biotherapeutics discovery.

Mail contact :

Instrument and consumables

In many cell screening operations Ab secreting hybridomas, cell line development

Co-development programs with pharma/biotech on game changing application, where no other tech can go, with tailor-made assays, high value results. This model will allow to generate the first revenue (FTE + success fees) in 2023.

– Bench-top instrument and consumables sales where MicroOmix will bring speed and higher performance on established recurrent needs, standard conditions, large user market.